Results 141 to 150 of about 21,902 (242)

Beyond <i>SGCE</i>: expanding the clinical and molecular spectrum of <i>KCTD17</i>- and <i>KCNN2</i>-related myoclonus-dystonia. [PDF]

Front Neurol
Krygier M, Sitek EJ, Chylińska M, Ziętkiewicz S, Zawadzka M, Dulski J, Schinwelski M, Kostrzewa G, Wierzba J, Płoski R, Zech M, Mazurkiewicz-Bełdzińska M.   +11 more
europepmc   +1 more source

Polypharmacy's paradox: accelerated decline in a rare case of Lafora body disease. [PDF]

Postep Psychiatr Neurol
Hussain T, Gupta K, Tiwari A, Mishra PS.
europepmc   +1 more source

Risk‐Benefit Considerations in Deep Brain Stimulation Discontinuation for Late‐Stage Parkinson's Disease

Movement Disorders Clinical Practice, Volume 13, Issue 8, Page 1918-1925, August 2026.
ABSTRACT Background Management of deep brain stimulation (DBS) in late‐stage Parkinson's disease (LSPD) remains challenging, particularly when deciding whether to continue or discontinue stimulation, and evidence on risk–benefit considerations is limited. Objectives To identify key factors to improve decision‐making in DBS management for LSPD patients.
Pietro Antenucci, Andrea Gozzi, Fabiana Colucci, Federica Pes, Jay Guido Capone, Alba Scerrati, Michele Alessandro Cavallo, Maura Pugliatti, Daniela Gragnaniello, Mariachiara Sensi   +9 more
wiley   +1 more source

Effect of oliceridine pretreatment on etomidate-induced myoclonus: a prospective, randomized, double-blind, controlled study. [PDF]

Front Med (Lausanne)
Sun Q, Wang X, Chen Z, Dong G, Shi X, Yu S, Xiao H, Ji F.   +7 more
europepmc   +1 more source

Palatal Myoclonus [PDF]

Proceedings of the Royal Society of Medicine, 1969
openaire   +2 more sources

Coping Behavior in Patients with Parkinson's Disease Prior to Subthalamic Deep Brain Stimulation and Association with Psychiatric Symptoms, Quality of Life and Neuropsychological Status

Movement Disorders Clinical Practice, Volume 13, Issue 8, Page 1886-1894, August 2026.
Abstract Background Coping behavior of Parkinson's disease (PD) patients undergoing subthalamic Deep Brain Stimulation (STN‐DBS) is poorly understood. Identifying patients with ineffective coping could help prepare them better for surgery. Objectives To clarify coping of PD patients preoperatively and the relation with psychiatric symptoms, quality of ...
Roy Brian Kuiper, Victor Jacobus Geraedts, Niels Anthony van der Gaag, Carel Frederik Ernst Hoffmann, Esther Lauwen, Rodi Zutt, Dirk Adrianus van der Zwart, Hubertus Anthonius Maria Middelkoop, Maria Fiorella Contarino   +8 more
wiley   +1 more source

An 18-fluorodeoxyglucose-PET study in <i>SGCE</i> positive and negative myoclonus-dystonia. [PDF]

Brain Commun
Timmers ER, Dijkhuis HCJ, Marapin RS, de Jong BM, Peretti DE, Dalenberg JR, Tijssen MAJ.   +6 more
europepmc   +1 more source

Subthalamic Nucleus Deep Brain Stimulation Improves Kinetic Tremor in Parkinson's Disease

Movement Disorders Clinical Practice, Volume 13, Issue 8, Page 1926-1932, August 2026.
Abstract Background Although resting tremor is a characteristic feature of Parkinson's disease (PD), many patients also suffer from action tremor. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is effective in reducing motor symptoms. However, it is unclear to what extent STN‐DBS improves action tremor in PD, particularly kinetic tremor.
Iwan Grooters, Bart E.K.S. Swinnen, Yarit Wiggerts, Maarten Bot, Pepijn van den Munckhof, P. Rick Schuurman, Martijn Beudel, Rob M.A. de Bie, Arthur W.G. Buijink   +8 more
wiley   +1 more source

Movement Disorders in Scrub Typhus: A Systematic Review. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Garg RK, Pandey S, Jain A, Karoli R, Suresh V, Singhal S.   +5 more
europepmc   +1 more source

Chronic lead encephalopathy in an adult: A case report and literature review. [PDF]

Clin Park Relat Disord
Rim T, Asmaa S, Hajar K, Kamal H, Salma B, Bouchra EM, Rafai MA, Hicham EO.   +7 more
europepmc   +1 more source